(Q33891866)

English

Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer (English)

1 reference

Europe PubMed Central

29 July 2017

1 reference

based on heuristic

inferred from title

Erb-b2 receptor tyrosine kinase 2

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Newman SP

1

1 reference

Europe PubMed Central

29 July 2017

Bates NP

2

1 reference

Europe PubMed Central

29 July 2017

Vernimmen D

3

1 reference

Europe PubMed Central

29 July 2017

Parker MG

4

1 reference

Europe PubMed Central

29 July 2017

Hurst HC

5

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

1 January 2000

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

19

1 reference

Europe PubMed Central

29 July 2017

490-497

1 reference

Europe PubMed Central

29 July 2017

4

1 reference

Europe PubMed Central

29 July 2017

https://scigraph.springernature.com/pub.10.1038/sj.onc.1203416

0 references

Oestrogen and epidermal growth factor down-regulate erbB-2 oncogene protein expression in breast cancer cells by different mechanisms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

An intron 1 enhancer element mediates oestrogen-induced suppression of ERBB2 expression.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Different binding specificities and transactivation of variant CRE's by CREB complexes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Predictive value of SRC-1 for tamoxifen response of recurrent breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Stochastic appearance of mammary tumors in transgenic mice carrying the MMTV/c-neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Molecular basis of agonism and antagonism in the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

The enhanceosome and transcriptional synergy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

A signature motif in transcriptional co-activators mediates binding to nuclear receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

The cellular transcription factor CREB corresponds to activating transcription factor 47 (ATF-47) and forms complexes with a group of polypeptides related to ATF-43.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Steroid receptor coactivator-1 interacts with serum response factor and coactivates serum response element-mediated transactivations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Steroid receptor coactivator-1 coactivates activating protein-1-mediated transactivations through interaction with the c-Jun and c-Fos subunits

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Requirement for neuregulin receptor erbB2 in neural and cardiac development

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Recruitment of CBP/p300 by the IFN beta enhanceosome is required for synergistic activation of transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Steroid receptor coactivator-1 interacts with the p50 subunit and coactivates nuclear factor kappaB-mediated transactivations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Breast cancer biology blossoms in the clinic.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Sequence and characterization of a coactivator for the steroid hormone receptor superfamily

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Estrogen suppression of erbB2 expression is associated with increased growth rate of ZR-75-1 human breast cancer cells in vitro and in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

neu tack on neuregulin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

21 January 2018

Characterization of ligand-dependent phosphorylation of the estrogen receptor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

7 January 2021

based on heuristic

inferred from DOI database lookup

ATF-2 contains a phosphorylation-dependent transcriptional activation domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

7 January 2021

based on heuristic

inferred from DOI database lookup

Nuclear receptor coregulators: cellular and molecular biology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

7 January 2021

based on heuristic

inferred from DOI database lookup

ERBB2 oncogene in human breast cancer and its clinical significance

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203416

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.ONC.1203416

1 reference

Europe PubMed Central

29 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33891866&oldid=1609336587"